New York State Psychiatric Institute [clinicaltrials_resource:ff3c5f0a438dd1e4eb9e98c44ce6103d]
Ragy R Girgis, MD [clinicaltrials_resource:0476fd913bf6048a94eb8764f57e78f9]Joanna Steinglass, MD [clinicaltrials_resource:05c2705a020ee606162eed9face1f72f]Laura Mufson, PhD [clinicaltrials_resource:0611d0d9104caa2c7d3f250688f48593]Michael Devlin, M.D. [clinicaltrials_resource:0696ec80ac407485b6fa7f8706cf3dac]Judith G Rabkin, PhD [clinicaltrials_resource:074c4effa3eefbf4859f7144275bf052]Barbara H. Stanley, PhD [clinicaltrials_resource:07f530496938e90c5524a40c7c89a3cd]Stephen J Donovan, MD [clinicaltrials_resource:0b06b66b81c20f5649f1b9255f0fdd74]Jonathan Posner, MD [clinicaltrials_resource:0c42cfeb782617a60b6ba0069da11ec5]Jonathan Posner, MD [clinicaltrials_resource:0d8f6df644a631e75ba997e782ad1e30]S. Rob Vorel, MD, PhD [clinicaltrials_resource:0f4c0a684151f9a28fd264bbf35ed822]Jeffrey M Miller, M.D. [clinicaltrials_resource:1454bc1cf47548c47da8e3e48060f0fc]Abraham Kroon, MD, PhD [clinicaltrials_resource:1526800ff7e961797416facd992a3b32]John J. Mariani, MD [clinicaltrials_resource:1703a977bb1fe0c21e02e868f136f428]Jeffrey A Lieberman, MD [clinicaltrials_resource:1752f9abae133540ba8f7a2465aac839]Ragy R Girgis, MD [clinicaltrials_resource:17e30c5eacc36d98b42de2bedca1b825]Jonathan Stewart, M.D. [clinicaltrials_resource:1c8ddd357bfed7aa964d5d5faab6760c]Brian A Fallon, MD [clinicaltrials_resource:1e5ef8a6add6c884b7543604ae932e27]Jennifer Jones [clinicaltrials_resource:1fb416276f152c20d45c6dfb5d041b0c]Bret Rutherford, MD [clinicaltrials_resource:1fc200bcd75b432997ebb80b75781a8a]Jeffrey M Miller, M.D. [clinicaltrials_resource:24661dde2fd4493093e5734ad10ae7a1]Margaret Haney, Ph.D [clinicaltrials_resource:253d48240385faac94585e19f2cacab7]Jeffrey Lieberman, MD [clinicaltrials_resource:256fc3fc512bad31b5c226cca6ba5d24]Jeffrey M Miller, M.D. [clinicaltrials_resource:2bac5f546014b17985f9511dd8a103c7]Margaret Haney, Ph.D. [clinicaltrials_resource:2c9de8b37377e8c39245f9aa83536f24]Eleanor L McGlinchey, Ph.D. [clinicaltrials_resource:2db997a227484bb382cd1835cefd490c]Eleanor L McGlinchey, Ph.D. [clinicaltrials_resource:2e06ce6f0f9848a1d583985bf78739d7]Helen Blair Simpson, MD, PhD [clinicaltrials_resource:30fce976eaebad5c817f94ff9d17fea1]Steven P. Roose, MD [clinicaltrials_resource:31e7218ae8dd3566c530cdf11f5be8dd]Gregory Pelton, M.D. [clinicaltrials_resource:34b72fcdf92318bc47ad8cacdfca53c1]Margaret Haney, PhD [clinicaltrials_resource:34d0f6c32d3cb903fb4f17131cdf3404]Antonio Mantovani, MD [clinicaltrials_resource:362c8a849a978171e6495b6a22ef211d]Eleanor L McGlinchey, Ph.D. [clinicaltrials_resource:3746ab773d1e51da17d63a52f6dae328]Roberto Lewis-Fernandez, MD [clinicaltrials_resource:3b2cb94dece387917eee1aa6ce487ba0]Ragy R Girgis, MD [clinicaltrials_resource:3c6e2de7fc88726134db213ebbcec666]Joanna Steinglass, MD [clinicaltrials_resource:3df77442c7ac04b5384bb5c106ae64f5]Herbert Kleber, MD [clinicaltrials_resource:3eea7e5c134e944b69227d34d61eb2ab]Bret Rutherford, MD [clinicaltrials_resource:416b65c19954db58ed194472e91c3949]Joan Prudic, MD [clinicaltrials_resource:425be29c0afb0c22db35ab13a16e4196]Carlos Blanco, MD, PhD [clinicaltrials_resource:429e69f4ba0f34f76f6209e215478974]Michael Liebowitz, MD [clinicaltrials_resource:46203c48d2d9eb9be2f59fc5cf8505ff]
affiliation [clinicaltrials_vocabulary:affiliation]
IV Cocaine Abuse: A Laboratory Model - 1 [clinicaltrials:NCT00000212]IV Cocaine Abuse: A Laboratory Model - 2 [clinicaltrials:NCT00000213]IV Cocaine Abuse: A Laboratory Model - 3 [clinicaltrials:NCT00000214]A Laboratory Model for Heroin Abuse Medications - 8 [clinicaltrials:NCT00000273]Early Phase II Trials for Cocaine Medication Development - 1 [clinicaltrials:NCT00000317]clinicaltrials:NCT00000368clinicaltrials:NCT00000378clinicaltrials:NCT00006172clinicaltrials:NCT00006517clinicaltrials:NCT00009217Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS) [clinicaltrials:NCT00018863]clinicaltrials:NCT00045903clinicaltrials:NCT00045916clinicaltrials:NCT00057642clinicaltrials:NCT00061087HIV Counseling Intervention for Methadone-Maintained Patients - 2 [clinicaltrials:NCT00061100]Enhancing the Outcome of Skills Training for People With Schizophrenia [clinicaltrials:NCT00069433]Treatment of Adolescent Suicide Attempters (TASA) [clinicaltrials:NCT00080158]clinicaltrials:NCT00118378clinicaltrials:NCT00125515clinicaltrials:NCT00131456clinicaltrials:NCT00134901clinicaltrials:NCT00136734The Effects of Memantine and Bupropion on Acute, Reinforcing, and Conditioned Effects of Cigarettes - 1 [clinicaltrials:NCT00136747]Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3 [clinicaltrials:NCT00136786]Effect of Smoking Exposure on Smoking Relapse Following Brief Abstinence - 2 [clinicaltrials:NCT00136838]clinicaltrials:NCT00141115clinicaltrials:NCT00142961Prescription Opioid Effects in Abusers Versus Non-Abusers [clinicaltrials:NCT00158184]clinicaltrials:NCT00208117clinicaltrials:NCT00217971Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults [clinicaltrials:NCT00218114]clinicaltrials:NCT00218543clinicaltrials:NCT00219349Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1 [clinicaltrials:NCT00238914]Effectiveness of Culturally Based Congruent Care in Treating Hispanics With Major Depressive Disorder [clinicaltrials:NCT00247195]Effectiveness of Sertraline in Treating Pathological Gamblers With a Diagnosis of Alcohol Dependence - 1 [clinicaltrials:NCT00249431]Mirtazapine for Treating Cocaine Dependent Individuals Who Also Suffer From Depression [clinicaltrials:NCT00249444]Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals [clinicaltrials:NCT00249483]clinicaltrials:NCT00251043
collaborator [clinicaltrials_vocabulary:collaborator]
IV Cocaine Abuse: A Laboratory Model - 1 [clinicaltrials:NCT00000212]IV Cocaine Abuse: A Laboratory Model - 2 [clinicaltrials:NCT00000213]IV Cocaine Abuse: A Laboratory Model - 3 [clinicaltrials:NCT00000214]A Laboratory Model for Heroin Abuse Medications - 8 [clinicaltrials:NCT00000273]Early Phase II Trials for Cocaine Medication Development - 1 [clinicaltrials:NCT00000317]clinicaltrials:NCT00000368clinicaltrials:NCT00000378clinicaltrials:NCT00006172clinicaltrials:NCT00006517clinicaltrials:NCT00009217Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS) [clinicaltrials:NCT00018863]clinicaltrials:NCT00045903clinicaltrials:NCT00045916clinicaltrials:NCT00057642clinicaltrials:NCT00061087HIV Counseling Intervention for Methadone-Maintained Patients - 2 [clinicaltrials:NCT00061100]Enhancing the Outcome of Skills Training for People With Schizophrenia [clinicaltrials:NCT00069433]Women's Treatment for Trauma and Substance Use Disorders - 1 [clinicaltrials:NCT00078156]Treatment of Adolescent Suicide Attempters (TASA) [clinicaltrials:NCT00080158]HIV/STD Safer Sex Skills Groups for Women in Drug Treatment Programs - 1 [clinicaltrials:NCT00084188]Transcranial Magnetic Stimulation (TMS) and Obsessive Compulsive Disorder (OCD) [clinicaltrials:NCT00106249]clinicaltrials:NCT00118378clinicaltrials:NCT00125515clinicaltrials:NCT00131456clinicaltrials:NCT00134901clinicaltrials:NCT00136734The Effects of Memantine and Bupropion on Acute, Reinforcing, and Conditioned Effects of Cigarettes - 1 [clinicaltrials:NCT00136747]Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3 [clinicaltrials:NCT00136786]Effect of Smoking Exposure on Smoking Relapse Following Brief Abstinence - 2 [clinicaltrials:NCT00136838]clinicaltrials:NCT00141115clinicaltrials:NCT00142961Prescription Opioid Effects in Abusers Versus Non-Abusers [clinicaltrials:NCT00158184]clinicaltrials:NCT00208117clinicaltrials:NCT00217971Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults [clinicaltrials:NCT00218114]clinicaltrials:NCT00218543clinicaltrials:NCT00219349Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1 [clinicaltrials:NCT00238914]Effectiveness of Culturally Based Congruent Care in Treating Hispanics With Major Depressive Disorder [clinicaltrials:NCT00247195]Effectiveness of Sertraline in Treating Pathological Gamblers With a Diagnosis of Alcohol Dependence - 1 [clinicaltrials:NCT00249431]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Adam Bisaga, MD, Principal Investigator, New York State Psychiatric Institute [clinicaltrials_resource:206c3f3fc803f011628e9a6cc9d26abe]Susan Tross, Ph.D., New York State Psychiatric Institute [clinicaltrials_resource:7b3319b5d1a7046045343ce23b059583]Jonathon W. Stewart, New York State Psychiatric Institute [clinicaltrials_resource:8ccae781c6aeb43802a3c51abb6094c6]Denise Hien, Ph.D., New York State Psychiatric Institute [clinicaltrials_resource:b33fd49ce8d183cd042943a53e14c37f]
organization [clinicaltrials_vocabulary:organization]
IV Cocaine Abuse: A Laboratory Model - 1 [clinicaltrials:NCT00000212]IV Cocaine Abuse: A Laboratory Model - 2 [clinicaltrials:NCT00000213]IV Cocaine Abuse: A Laboratory Model - 3 [clinicaltrials:NCT00000214]A Laboratory Model for Heroin Abuse Medications - 8 [clinicaltrials:NCT00000273]Early Phase II Trials for Cocaine Medication Development - 1 [clinicaltrials:NCT00000317]clinicaltrials:NCT00000368clinicaltrials:NCT00000378clinicaltrials:NCT00006172clinicaltrials:NCT00006517clinicaltrials:NCT00009217Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS) [clinicaltrials:NCT00018863]clinicaltrials:NCT00045903clinicaltrials:NCT00045916clinicaltrials:NCT00057642clinicaltrials:NCT00061087HIV Counseling Intervention for Methadone-Maintained Patients - 2 [clinicaltrials:NCT00061100]Enhancing the Outcome of Skills Training for People With Schizophrenia [clinicaltrials:NCT00069433]Treatment of Adolescent Suicide Attempters (TASA) [clinicaltrials:NCT00080158]Transcranial Magnetic Stimulation (TMS) and Obsessive Compulsive Disorder (OCD) [clinicaltrials:NCT00106249]clinicaltrials:NCT00118378clinicaltrials:NCT00125515clinicaltrials:NCT00131456clinicaltrials:NCT00134901clinicaltrials:NCT00136734clinicaltrials:NCT00141115clinicaltrials:NCT00142961Prescription Opioid Effects in Abusers Versus Non-Abusers [clinicaltrials:NCT00158184]clinicaltrials:NCT00208117clinicaltrials:NCT00217971Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults [clinicaltrials:NCT00218114]clinicaltrials:NCT00218543clinicaltrials:NCT00219349Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1 [clinicaltrials:NCT00238914]Effectiveness of Culturally Based Congruent Care in Treating Hispanics With Major Depressive Disorder [clinicaltrials:NCT00247195]Effectiveness of Sertraline in Treating Pathological Gamblers With a Diagnosis of Alcohol Dependence - 1 [clinicaltrials:NCT00249431]Mirtazapine for Treating Cocaine Dependent Individuals Who Also Suffer From Depression [clinicaltrials:NCT00249444]Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals [clinicaltrials:NCT00249483]clinicaltrials:NCT00251043Long Duration Stimulant Treatment Study of Preschoolers With ADHD-Feasibility Study [clinicaltrials:NCT00257725]clinicaltrials:NCT00262223
source [clinicaltrials_vocabulary:source]
New York State Psychiatric Institute [clinicaltrials_resource:ff3c5f0a438dd1e4eb9e98c44ce6103d]
Bio2RDF identifier
ff3c5f0a438dd1e4eb9e98c44ce6103d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ff3c5f0a438dd1e4eb9e98c44ce6103d
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:ff3c5f0a438dd1e4eb9e98c44ce6103d
title
New York State Psychiatric Institute
@en
type
label
New York State Psychiatric Ins ...... c5f0a438dd1e4eb9e98c44ce6103d]
@en